Our company

Boehringer Ingelheim was founded in 1885 by Albert Boehringer and remains a family-owned company. Today we are amongst the world’s 20 leading pharmaceutical companies.

Annual sales are €12.6 billion worldwide (2010) and 24% of the net sales from our Prescription Medicine business is invested into research and development. We now employ more than 42,000 people. We are committed to remaining family-owned and Albert’s great grandson, Christian Boehringer, is the Chair of the Shareholders’ Committee which manages 145 affiliated companies in 50 countries around the globe. Our headquarters remain in Ingelheim, near Frankfurt in Germany.

Our vision, ‘Value through Innovation’, mirrors our founder’s own belief in the importance of innovative thinking and that, as well as being financially profitable, products should be pioneering and of genuine benefit to patients. Our independent status frees us from stock market expectations, and allows for long-term strategies, rather than short-term priorities.

In the United Kingdom, Boehringer Ingelheim was established in 1962 and is one of the fastest growing pharmaceutical companies in the UK, with total sales of £397.5 million in 2010 (independent audit). The business focuses on clinical research, data management, sales and marketing.

We are involved in three key healthcare areas: Prescription Medicines, Over-The-Counter (OTC) products and Animal Health. In each sector, we have world-class medicines to treat patients.